drug-information.ru |
|Glatiramer Acetate |
Drugs search, click the first letter of a drug name: | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9 Home Glatiramer AcetatePronouncation: (glah-TEER-ah-mer ASS-eh-tate)Class: Immunosuppressive Trade Names: Mechanism of ActionPharmacologyUnknown. May modify the immune processes that are thought to be responsible for multiple sclerosis (MS). Indications and UsageTo reduce the frequency of relapses in patients with relapsing-remitting MS. ContraindicationsHypersensitivity to glatiramer acetate or mannitol. Dosage and AdministrationAdultsSubcutaneous 20 mg q day. General Advice
Storage/StabilityStore prefilled syringes in refrigerator (36° to 46°F). Protect from freezing and exposure to light. Discard any syringes that have been frozen. If a refrigerator is not available, the syringes may be stored at room temperature (59° to 86°F) for up to 7 days. Drug InteractionsNone well documented. Laboratory Test InteractionsNone well documented. Adverse ReactionsCardiovascularVasodilation (27%); palpitation (17%); syncope, tachycardia (5%); hypertension (at least 1%); thrombosis, peripheral vascular disease, pericardial effusion, MI, deep thrombophlebitis, coronary occlusion, CHF, cardiomyopathy, cardiomegaly, arrhythmia, angina pectoris (postmarketing). CNSAsthenia (41%); anxiety (23%); hypertonia (22%); tremor (7%); vertigo (6%); migraine (5%); agitation (4%); foot drop (3%); confusion, nervousness, nystagmus, speech disorder (2%); abnormal dreams, emotional lability, stupor (at least 1%); meningitis, CNS neoplasm, cerebrovascular accident, brain edema, abnormal dreams, aphasia, convulsion, neuralgia, myelitis (postmarketing). DermatologicPruritus, rash (18%); sweating (15%); erythema, herpes simplex, urticaria (4%); skin nodule (2%); eczema, herpes zoster, pustular rash, skin atrophy, warts (at least 1%). EENTRhinitis (14%); eye pain (7%); eye disorder (4%); visual field changes (at least 1%); glaucoma, blindness, visual field defect (postmarketing). GINausea (22%); diarrhea (12%); anorexia (8%); vomiting (6%); GI disorder (5%); gastroenteritis (3%); bowel urgency, oral moniliasis, salivary gland enlargement, tooth caries and ulcerations (at least 1%); tongue edema, stomach ulcer, GI hemorrhage, eructation (postmarketing). GenitourinaryUrinary urgency (10%); vaginal moniliasis (8%); dysmenorrhea (6%); amenorrhea, hematuria, impotence, menorrhagia, suspicious papanicolaou smear, urinary frequency, vaginal hemorrhage (at least 1%); urogenital neoplasm, urine abnormality, ovarian carcinoma, nephrosis, kidney failure, breast carcinoma, bladder carcinoma, urinary frequency (postmarketing). Hematologic-LymphaticLymphadenopathy (12%); ecchymosis (8%); thrombocytopenia, lymphoma-like reaction, acute leukemia (postmarketing). HepaticAbnormal liver function, liver damage, hepatitis, liver cirrhosis, cholelithiasis (postmarketing). LocalInjection site pain (73%); injection site erythema (66%); injection site Inflammation (49%); injection site pruritus (40%); injection site mass (27%); injection site induration (13%); injection site welt (11%); injection site hemorrhage, injection site urticaria (5%); injection site edema, atrophy, abscess or hypersensitivity (at least 1%). Metabolic-NutritionalWeight gain (3%); hypercholesterolemia (postmarketing). MusculoskeletalArthralgia (24%); back pain (16%); neck pain (8%); rheumatoid arthritis, generalized spasm (postmarketing). RespiratoryDyspnea (19%); bronchitis (9%); Laryngismus (5%); hyperventilation; hay fever (at least 1%); pulmonary embolus, pleural effusion, lung carcinoma, (postmarketing). Miscellaneousinfection (50%); pain (28%); chest pain (21%); flu syndrome (19%); peripheral edema (7%); fever (8%); face edema (6%); bacterial infection (5%); chills (4%); edema (3%); cyst (2%); sepsis, lupus erythematosus syndrome, hydrocephalus, enlarged abdomen, allergic reaction, anaphylactoid reaction (postmarketing). PrecautionsPregnancyCategory B . LactationUndetermined. ChildrenSafety and efficacy in children younger than 18 yr of age not established. ImmunityCould possibly interfere with useful immune function (eg, decreased defense against infection or tumor surveillance). Immediate postinjection reactionApproximately 10% of patients experience a constellation of symptoms immediately after injection. Symptoms may include the following: flushing, chest pain, palpitations, anxiety, dyspnea, constriction of throat, urticaria. These symptoms are usually transient and self-limited and generally occur several months after starting therapy. Patient Information
Where can I get more information about Glatiramer Acetate ? We recommend to use www.Drugs.com Typical mistypes for Glatiramer Acetate flatiramer acetate, vlatiramer acetate, blatiramer acetate, hlatiramer acetate, ylatiramer acetate, tlatiramer acetate, gkatiramer acetate, gpatiramer acetate, goatiramer acetate, glztiramer acetate, glstiramer acetate, glwtiramer acetate, glqtiramer acetate, glariramer acetate, glafiramer acetate, glagiramer acetate, glayiramer acetate, gla6iramer acetate, gla5iramer acetate, glaturamer acetate, glatjramer acetate, glatkramer acetate, glatoramer acetate, glat9ramer acetate, glat8ramer acetate, glatieamer acetate, glatidamer acetate, glatifamer acetate, glatitamer acetate, glati5amer acetate, glati4amer acetate, glatirzmer acetate, glatirsmer acetate, glatirwmer acetate, glatirqmer acetate, glatiraner acetate, glatiraker acetate, glatirajer acetate, glatiramwr acetate, glatiramsr acetate, glatiramdr acetate, glatiramrr acetate, glatiram4r acetate, glatiram3r acetate, glatiramee acetate, glatiramed acetate, glatiramef acetate, glatiramet acetate, glatirame5 acetate, glatirame4 acetate, glatiramer zcetate, glatiramer scetate, glatiramer wcetate, glatiramer qcetate, glatiramer axetate, glatiramer avetate, glatiramer afetate, glatiramer adetate, glatiramer acwtate, glatiramer acstate, glatiramer acdtate, glatiramer acrtate, glatiramer ac4tate, glatiramer ac3tate, glatiramer acerate, glatiramer acefate, glatiramer acegate, glatiramer aceyate, glatiramer ace6ate, glatiramer ace5ate, glatiramer acetzte, glatiramer acetste, glatiramer acetwte, glatiramer acetqte, glatiramer acetare, glatiramer acetafe, glatiramer acetage, glatiramer acetaye, glatiramer aceta6e, glatiramer aceta5e, glatiramer acetatw, glatiramer acetats, glatiramer acetatd, glatiramer acetatr, glatiramer acetat4, glatiramer acetat3, latiramer acetate, gatiramer acetate, gltiramer acetate, glairamer acetate, glatramer acetate, glatiamer acetate, glatirmer acetate, glatiraer acetate, glatiramr acetate, glatirame acetate, glatirameracetate, glatiramer cetate, glatiramer aetate, glatiramer actate, glatiramer aceate, glatiramer acette, glatiramer acetae, glatiramer acetat, lgatiramer acetate, galtiramer acetate, gltairamer acetate, glaitramer acetate, glatriamer acetate, glatiarmer acetate, glatirmaer acetate, glatiraemr acetate, glatiramre acetate, glatirame racetate, glatiramera cetate, glatiramer caetate, glatiramer aectate, glatiramer acteate, glatiramer aceatte, glatiramer acettae, glatiramer acetaet, gglatiramer acetate, gllatiramer acetate, glaatiramer acetate, glattiramer acetate, glatiiramer acetate, glatirramer acetate, glatiraamer acetate, glatirammer acetate, glatirameer acetate, glatiramerr acetate, glatiramer acetate, glatiramer aacetate, glatiramer accetate, glatiramer aceetate, glatiramer acettate, glatiramer acetaate, glatiramer acetatte, glatiramer acetatee, etc.
|